drugset / Trial / NCT01115855

Clinical Study Of Eplerenone In Japanese Patients With Chronic Heart Failure

NCT01115855

Phase 3 Completed 221 enrolled Viatris Inc.
RandomizedParallel-groupTriple-blindTreatment

Summary

A study to compare the efficacy and safety of eplerenone in Japanese chronic heart failure patients with placebo.

Timeline

Start
2010-07
Primary completion
2015-09
Completion
2015-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Eplerenone Unknown 25 mg
Subject Eplerenone Unknown 50 mg

Indications